LabCompass

Publications

84

Citations

2,699

Est. group size

Recurring co-author estimate

Active years

54

Publishing since 1973

Research summary
AI-generated

Steven M. Johnson studies proteins that help other proteins fold correctly, known as molecular chaperones (such as the GroEL/ES and HSP70 systems), and how they can be targeted with small-molecule inhibitors to treat infections and disease. His work spans drug discovery against parasites like those causing malaria and African sleeping sickness, as well as inhibitors of protein misfolding disorders such as transthyretin amyloidosis. The publication record also includes contributions to a range of clinical and biomedical topics.

Molecular chaperones and protein foldingChaperonin inhibitors as antibioticsAntiparasitic drug discovery (malaria, trypanosomes)Amyloidosis inhibitors and protein misfoldingHigh-throughput substrate binding assays

Publication activity peaked around 2019 and has since settled to a steady, lower rate of roughly two to four papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.8/year recently
2017: 2 publications172018: 4 publications182019: 12 publications12192020: 1 publication202021: 3 publications212022: 3 publications222023: 4 publications232024: 4 publications242025: 2 publications252026: 1 publication26
Recent publications
Publishes in
  • Bioorganic & Medicinal Chemistry Letters×6
  • Bioorganic & Medicinal Chemistry×3
  • PMC×3
  • bioRxiv (Cold Spring Harbor Laboratory)×3
  • Journal of Medicinal Chemistry×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile